Search details
1.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Article
in English
| MEDLINE | ID: mdl-35644155
2.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Article
in English
| MEDLINE | ID: mdl-35644154
3.
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.
Gut
; 69(4): 658-664, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31285357
4.
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Lancet
; 390(10114): 2779-2789, 2017 12 23.
Article
in English
| MEDLINE | ID: mdl-29096949
5.
Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
J Pediatr Gastroenterol Nutr
; 64(1): 154-168, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27429428
6.
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.
J Crohns Colitis
; 18(3): 416-423, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37797293
7.
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease.
Adv Ther
; 40(9): 3896-3911, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37368103
8.
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease.
Adv Ther
; 40(5): 2311-2325, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36917429
9.
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
J Crohns Colitis
; 17(7): 1066-1078, 2023 Jul 05.
Article
in English
| MEDLINE | ID: mdl-36738443
10.
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study.
Inflamm Bowel Dis
; 26(10): 1562-1571, 2020 09 18.
Article
in English
| MEDLINE | ID: mdl-32105310
11.
FTF and LRH-1, two related but different transcription factors in human Caco-2 cells: their different roles in the regulation of bile acid transport.
Biochim Biophys Acta
; 1732(1-3): 31-7, 2005 Dec 30.
Article
in English
| MEDLINE | ID: mdl-16469397
12.
Wilson's disease and hemochromatosis.
Adolesc Med Clin
; 15(1): 175-94, xi, 2004 Feb.
Article
in English
| MEDLINE | ID: mdl-15272264
13.
Early detection of biliary atresia raises questions about etiology and screening.
Pediatrics
; 128(6): e1598-9, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-22106079
14.
c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter.
Gastroenterology
; 131(2): 554-67, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16890608
15.
Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
Liver Transpl
; 11(7): 788-795, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15973720
16.
Antioxidant effect of bilirubin and pediatric nonalcoholic fatty liver disease.
Pediatrics
; 124(6): e1240-1, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19948622
17.
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
Hepatology
; 40(1): 149-56, 2004 Jul.
Article
in English
| MEDLINE | ID: mdl-15239098
18.
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Gastroenterology
; 126(3): 756-64, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-14988830
19.
Novel surgical and pharmacological approaches to chronic cholestasis in children: partial external biliary diversion for intractable pruritus and xanthomas in Alagille Syndrome.
J Pediatr Gastroenterol Nutr
; 36(2): 296-7, 2003 Feb.
Article
in English
| MEDLINE | ID: mdl-12593401
Results
1 -
19
de 19
1
Next >
>>